Compare GMED & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | DECK |
|---|---|---|
| Founded | 2003 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 12.4B |
| IPO Year | 2012 | 1996 |
| Metric | GMED | DECK |
|---|---|---|
| Price | $83.19 | $88.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 23 |
| Target Price | $100.42 | ★ $122.45 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | 10.90 |
| EPS | ★ 2.00 | 0.94 |
| Revenue | $2,938,931,000.00 | ★ $5,472,296,000.00 |
| Revenue This Year | $11.13 | $11.16 |
| Revenue Next Year | $6.28 | $6.96 |
| P/E Ratio | ★ $41.27 | $91.91 |
| Revenue Growth | ★ 16.65 | 9.76 |
| 52 Week Low | $54.17 | $78.91 |
| 52 Week High | $101.40 | $125.45 |
| Indicator | GMED | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 35.02 |
| Support Level | $82.01 | N/A |
| Resistance Level | $82.23 | $105.61 |
| Average True Range (ATR) | 2.06 | 2.34 |
| MACD | -0.56 | -0.27 |
| Stochastic Oscillator | 5.54 | 6.64 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.